Beam Therapeutics Inc. R&D Expenses

R&D Expenses of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including R&D Expenses growth rates and interactive chart. Research and development (R&D) expenses are associated with the research and development of a company's goods or services. A company generally incurs R&D expenses in the process of finding and creating new products or services. It is an operating expense and can be deducted from a company's income taxes.


Highlights and Quick Summary

  • R&D Expenses for the quarter ending September 30, 2022 was $85.3 Million (a 14.39% increase compared to previous quarter)
  • Year-over-year quarterly R&D Expenses decreased by -11.88%
  • Annual R&D Expenses for 2021 was $387 Million (a 275.16% increase from previous year)
  • Annual R&D Expenses for 2020 was $103 Million (a 88.91% increase from previous year)
  • Annual R&D Expenses for 2019 was $54.6 Million (a 61.25% increase from previous year)
  • Twelve month R&D Expenses ending September 30, 2022 was $322 Million (a 10.52% increase compared to previous quarter)
  • Twelve month trailing R&D Expenses decreased by -16.81% year-over-year
Trailing R&D Expenses for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$322 Million $291 Million $262 Million $387 Million
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical R&D Expenses of Beam Therapeutics Inc.

Most recent R&D Expensesof BEAM including historical data for past 10 years.

Interactive Chart of R&D Expenses of Beam Therapeutics Inc.

Beam Therapeutics Inc. R&D Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $85.29 $74.56 $65.41
2021 $96.78 $54.62 $45.58 $190.11 $387.09
2020 $32.45 $29.83 $19.35 $21.55 $103.18
2019 $20.22 $12.54 $12.68 $9.18 $54.62
2018 $33.87
2017 $5.86

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology